HIF-1 alpha (HIF1A) Human shRNA Plasmid Kit (Locus ID 3091)
CAT#: TR320380
HIF1A - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 3 publications. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | HIF-1 alpha (HIF1A) Human shRNA Plasmid Kit (Locus ID 3091) |
Locus ID | 3091 |
UniProt ID | Q16665 |
Synonyms | bHLHe78; HIF-1-alpha; HIF-1A; HIF-1alpha; HIF1; HIF1-ALPHA; MOP1; PASD8 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | HIF1A - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 3091). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_001243084, NM_001530, NM_181054, NM_001530.1, NM_001530.2, NM_001530.3, NM_181054.1, NM_181054.2, NM_001243084.1, BC012527, BC012527.2, NM_001530.4, NM_181054.3 |
Summary | This gene encodes the alpha subunit of transcription factor hypoxia-inducible factor-1 (HIF-1), which is a heterodimer composed of an alpha and a beta subunit. HIF-1 functions as a master regulator of cellular and systemic homeostatic response to hypoxia by activating transcription of many genes, including those involved in energy metabolism, angiogenesis, apoptosis, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia. HIF-1 thus plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2011] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (3)
The use of this RNAi has been cited in the following citations: |
---|
Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease
,Li, X;Yao, QY;Liu, HC;Jin, QW;Xu, BL;Zhang, SC;Tu, CT;,
J. Cell. Mol. Med.
,PubMed ID 28378526
[HIF1A]
|
Hypoxia-Sensitive Epigenetic Regulation of an Antisense-Oriented lncRNA Controls WT1 Expression in Myeloid Leukemia Cells
,McCarty, G;Loeb, DM;,
PLoS ONE
,PubMed ID 25794157
[HIF1A]
|
Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion
,J Chen, N Imanaka, J Chen, J D Griffin,
British Journal of Cancer (15 December 2009) doi:10.1038/sj.bjc.6605486 Full Paper
[HIF1A]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...